Emerging Technology: Page 2

Study: Blood test improves bipolar disorder diagnosis through biomarkers

By Matt Limb

Diagnosis of bipolar disorder could be improved using a simple blood test to identify biomarkers associated with the condition, say researchers.

November 2, 2023

Qiagen, Myriad Genetics to collaborate on cancer companion diagnostics

By LabPulse.com staff writers

Qiagen and Myriad Genetics have formed a new master collaboration agreement on the development of companion diagnostic tests for cancer.

October 27, 2023

Software reduces DANGER of CRISPR-Cas9 by shedding light on off-target edits

By Nick Paul Taylor

A new software can improve the safety and utility of CRISPR-Cas9 gene editing by detecting off-target changes and eliminating the need for reference genomes, according to a paper published in Bioinformatics Advances.

October 27, 2023

Study: Proteomic profiling used to track effects of aging, diseases on the eyes

By LabPulse.com staff writers

In a study published in Cell, researchers used proteomic profiling and artificial intelligence (AI) modeling to determine biomarkers and track the progression and effects of aging and disease on the eyes.

October 24, 2023

Thermo Fisher to acquire proteomics firm Olink

By LabPulse.com staff writers

Thermo Fisher has announced plans to acquire Uppsala, Sweden-based proteomics company Olink for approximately $3.1 billion. The amount includes net cash of approximately $143 million.

October 17, 2023

U.K. startup Sparta Biodiscovery secures deal with Sartorius

By Matt Limb

London-based Sparta Biodiscovery has secured up to 3.5 million pounds ($4.3 million) in funding for the commercial rollout of its nanoparticle analyzers, which are used in the development of advanced medicines.

October 13, 2023

Dxcover targets 2025 launch for blood test that uses light to detect cancer

By Nick Paul Taylor

Dxcover is aiming to launch its brain cancer blood test to support the triage of symptomatic patients in Europe in 2025.

October 12, 2023

Researchers develop nanopore sequencing method for mapping disease biomarkers

By Matt Limb

A nanopore sequencing method that can map dozens of biomarkers at the same time has the potential to transform testing for heart disease and other conditions, say researchers.

October 11, 2023

ProciseDx receives FDA de novo authorization for therapeutic drug monitoring tests

By LabPulse.com staff writers

ProciseDx has received U.S. Food and Drug Administrtion (FDA) de novo marketing authorization for its point-of-care tests for monitoring levels of infliximab and adalimumab in patients being treated for inflammatory bowel diseases.

October 5, 2023

Protein panel improves Alzheimer’s diagnosis, predictions of disease progression

By Nick Paul Taylor

Quantifying certain proteins in cerebrospinal fluid could improve the diagnosis of Alzheimer's disease and prediction of disease progression, according to a paper in Science Translational Medicine.

October 3, 2023

Many British health trusts slow to adopt electronic records systems, shows BMJ survey

By Matt Limb

Many health organizations in England are still reliant on paper patient notes and drug charts, despite progress toward electronic records and prescribing, The BMJ has found.

September 22, 2023

Electronic DNA nanoballs detection enables fast, accurate, cheap pathogen detection

By Nick Paul Taylor

Electronic detection of DNA nanoballs could enable fast, accurate, and cheap identification of pathogens, according to a paper published in Science Advances.

September 18, 2023

Previous Page

Page 2 of 51

Next Page